Categories: News

WITHmyDOC’s Remote Patient Monitoring Platform Offers a COVID-19 Clinical Solution for Overcrowded Hospitals

FT. LAUDERDALE, Fla., Dec. 21, 2020  /PRNewswire/ — Less than six months after launching RPM@Home™, healthcare technology company WITHmyDOC is seeing the value of remote patient monitoring (RPM) come to the forefront as a solution to lessen the impact of COVID-19 on emergency rooms and hospitals.

With U.S. COVID-19 numbers continuing to surge – the latest report says the number of new cases has risen 51 percent over the past month – hospitals are nearing or at capacity of beds and ICU units. RPM, which allows some patients to have their oxygen level monitored at home, has emerged as a safe, effective way to free up hospital beds.

WITHmyDOC’s RPM@Home kit allows less severe COVID patients to be monitored daily without leaving their home using a tablet and pulse oximeter. Providers can keep an eye on the patient’s oxygen level while they are at home and make adjustments when necessary. The kit also allows physicians to set target parameters for each’s patient’s vital signs. The system will trigger a critical alert if the patient’s vital signs fall out of their normal range. At that point, with a COVID-19 patient, the physician can decide whether an at-home treatment modification is in order, whether the amount of oxygen the patient receives needs to change, or whether the patient needs to be admitted to the hospital. A unique feature of WITHmyDOC’s kit is that if the patient is on oxygen, the physician’s monitoring dashboard shows how much oxygen the patient is taking, in addition to their oxygen level.

“Using RPM@Home for less severe COVID patients is a risk mitigation tool that proactively protects patients, reduces the spread of infection and helps alleviate hospital capacity issues,” says Richard Rodriguez, CEO of WITHmyDOC. “The ability to monitor the patient’s oxygen level at home through RPM is the key to not having to do so in the hospital. It keeps patients at home where they can be cared for in a comfortable, familiar environment.”

In response to the crush of new COVID-19 patients in hospitals, the Centers for Medicare and Medicaid Services (CMS) recently launched its Acute Hospital Care at Home program, providing new allowances for hospitals to treat patients in their homes using telehealth and RPM options like RPM@Home. Designed for patients who meet acute inpatient or overnight observation admission criteria, the program considers the patient’s home to be part of the hospital.

According to CMS, hospitals already using RPM have found they can deliver hospital-level care in their patients’ homes with lower readmission rates, more physical mobility and a positive patient experience.

About WITHmyDOC

Based in Ft. Lauderdale, Fla., WITHmyDOC is a digital health company founded in 2019 that uses a web-based intelligence platform for remote patient monitoring to transform healthcare. We connect patients to their care teams, providing the real-time data needed to control symptom and disease progression. WITHmyDOC partners with health systems, physician practices and healthcare organizations to provide remote patient monitoring that facilitates proactive intervention for chronic care management and to support telehealth visits. For more information visit www.withmydoc.com

Media Contact:
Juliann Kaiser, 770.643-0615
jkaiser@kaisermarketinggroup.com

View original content:http://www.prnewswire.com/news-releases/withmydocs-remote-patient-monitoring-platform-offers-a-covid-19-clinical-solution-for-overcrowded-hospitals-301196662.html

SOURCE WITHmyDOC

Staff

Recent Posts

Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy

Toronto, Ontario--(Newsfile Corp. - February 3, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF)…

10 minutes ago

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

2 hours ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

2 hours ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

2 hours ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

2 hours ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

2 hours ago